Selective portal vein embolization (PVE) can produce atrophy of the embolized segments and compensatory hypertrophy of the contralateral segments, which increases the size of future liver remnant (FLR), expands the scope of liver resection, and reduces the incidence of postoperative liver insufficiency. In this paper, the authors address the PVE-related issues and research progress in this field.